HOME >> BIOLOGY >> NEWS
Anti cancer virotherapy well tolerated in first human administration, research finds

(Banff, Canada March 14, 2005) An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth has begun safety testing in human subjects.

The research was presented to the third International Meeting on Replicating Oncolytic Virus Therapeutics, on Friday 11 March by Newcastle University associate professor, Darren Shafren.

The technology is licensed to Australian Stock Exchange listed biotechnology company, Psiron Limited (ASX:PSX).

Professor Shafren has previously tested this virotherapy on cancer tumours in mice and this is the first testing in humans. Two patients only were approved to receive this virotherapy.

Professor Shafren reported to the conference that this research team had injected a single dose of Coxsackie A21 (CVA21) virus directly into the advanced melanoma tumours of these patients with end stage disease.

Both patients had many sites of spread melanoma tumours and injected and non-injected tumours were subsequently removed from the patients.

Professor Shafren's group observed no "systemic toxic effects or localised inflammation" as a result of the injections of the viral material and basic blood chemistry and liver enzyme levels remain unchanged in the these two patients.

Professor Shafren told conference delegates that these findings suggested that administration of a single dose of CVA21 directly into a cancerous tumour was well tolerated.

"Administration of CVA21 may be of potential therapeutic benefit in controlling the spread of melanoma," Professor Shafren said.

CVA21 is one of a small group of naturally occurring rather than genetically modified viruses the Shafren team has been investigating as potential therapies for different hard to treat malignancies including melanoma and ovarian cancer.

These viruses occur naturally and routinely in the community causing m
'"/>

Contact: David Sheon
dsheon@sciwords.com
202 518 6321
SciWords
14-Mar-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Newly created cancer stem cells could aid breast cancer research
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. No evidence that widely prescribed statins protect against prostate cancer
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. New test improves detection of liver cancer
9. High-intensity ultrasound may launch attack on cancer, wherever it lurks
10. Unknotting DNA clue to cancer syndrome
11. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... 23, 2020 , ... First Aid Africa, a Scottish charity ... and manufacturer of innovative portable renewable energy equipment, have announced the success of ... COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable solar power ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb Crew reported ... director of stem cell biotechnology company Asymmetrex . Superb Crew decided to highlight ... it would begin offering free tissue stem cell counting at its company ...
(Date:6/19/2020)... ... June 18, 2020 , ... Join experts from Envigo Lauren Klaskala, ... live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). ... engineer new models. However, while modifying the genome may be more straightforward, the challenge ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... (PRWEB) , ... May 19, 2020 , ... Eaton Square ... the addition of Popper and Company, a biotechnology and medical technology-focused strategy and M&A ... to grow in the United States, linking US and Asia Pacific healthcare innovators with ...
(Date:5/15/2020)... FREDERICK, Md. (PRWEB) , ... ... ... a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks ... RoosterCollect™-EV-CC to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles ...
(Date:5/15/2020)... ... 14, 2020 , ... This new service offers clients a way to speak ... quickly as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide ... , Lachman OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 ...
(Date:5/14/2020)... , ... May 12, 2020 , ... ... JCS as the new distribution partner for all personal care ingredients in Russia ... portfolio and DuPont preservative portfolio for personal care. , The GENENCARE®OSMS ...
Breaking Biology Technology:
Cached News: